HY-123931-10mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-100mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-5mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-50mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-1mL
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-N0510-10mg
|
MedChemexpress LLC
|
Aristolochic acid A [CAS 313-67-7]
|
|
Cancer-programmed cell death
|
|
HY-N0510-25mg
|
MedChemexpress LLC
|
Aristolochic acid A [CAS 313-67-7]
|
|
Cancer-programmed cell death
|
|
HY-N0510-5mg
|
MedChemexpress LLC
|
Aristolochic acid A [CAS 313-67-7]
|
|
Cancer-programmed cell death
|
|
HY-N0510-1mL
|
MedChemexpress LLC
|
Aristolochic acid A [CAS 313-67-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-P74200-50ug
|
MedChemexpress LLC
|
DEP-1/CD148, Human (341a.a, His)
|
|
|
|
HY-118529-10mg
|
MedChemexpress LLC
|
JUN-1111 [CAS 874351-38-9]
|
|
|
|
HY-118529-100mg
|
MedChemexpress LLC
|
JUN-1111 [CAS 874351-38-9]
|
|
|
|
HY-118529-25mg
|
MedChemexpress LLC
|
JUN-1111 [CAS 874351-38-9]
|
|
|
|
HY-118529-5mg
|
MedChemexpress LLC
|
JUN-1111 [CAS 874351-38-9]
|
|
|
|
HY-118529-50mg
|
MedChemexpress LLC
|
JUN-1111 [CAS 874351-38-9]
|
|
|
|
HY-155847-10mg
|
MedChemexpress LLC
|
LYP-IN-3
|
|
|
|
HY-155847-25mg
|
MedChemexpress LLC
|
LYP-IN-3
|
|
|
|
HY-155847-5mg
|
MedChemexpress LLC
|
LYP-IN-3
|
|
|
|